Market Closed

DWTX
Dogwood Therapeutics
$ 1.11
-0.89%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Dogwood Therapeutics News

Latest Dogwood Therapeutics Stock News & DWTX Headlines

Dogwood Therapeutics Announces Third Quarter 2026 Financial Results
10 days ago | globenewswire.com
Dogwood to Participate in the 2026 Maxim Growth Summit
a month ago | globenewswire.com
Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial
2 months ago | globenewswire.com
Dogwood Therapeutics, Inc. (DWTX) Discusses Halneuron and Pipeline Advances for Chemotherapy-Induced Neuropathic Pain Transcript
2 months ago | seekingalpha.com
Dogwood Therapeutics Nears Phase 2b Readout for Halneuron Neuropathic Pain Treatment
2 months ago | marketbeat.com
Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
3 months ago | globenewswire.com
Dogwood Therapeutics (NASDAQ:DWTX) Shares Up 4.3% – What’s Next?
3 months ago | defenseworld.net
Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026
4 months ago | globenewswire.com
Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board
5 months ago | globenewswire.com
Dogwood Therapeutics, Inc. (DWTX) Shareholder/Analyst Call Prepared Remarks Transcript
5 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

DWTX
Dogwood Therapeutics
$ 1.11
-0.89%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago